Nestlé Sells Gut-Health Test Maker Prometheus Labs, Layoffs Expected
Xconomy
JULY 10, 2019
Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science , the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s workforce. Precision IBD, which is also based in San Diego, is a drug and diagnostic developer that’s focused on inflammatory bowl disease, and has a direct tie to Prometheus: Precision’s chief medical officer, Steph Targan, is a
Let's personalize your content